The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Human Parainfluenza Viruses Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
The global Human Parainfluenza Viruses Diagnostics market size is expected to reach US$ 935.8 million by 2029, growing at a CAGR of 8.3% from 2023 to 2029. The market is mainly driven by the significant applications of Human Parainfluenza Viruses Diagnostics in various end use industries. The expanding demands from the Diagnostic Centers, Hospitals and Clinic,, are propelling Human Parainfluenza Viruses Diagnostics market. HPV Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Follow-up HPV Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Parainfluenza Viruses Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Parainfluenza Viruses Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Parainfluenza Viruses Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Parainfluenza Viruses Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Parainfluenza Viruses Diagnostics covered in this report include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD and Seegene, etc.
The global Human Parainfluenza Viruses Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene
Global Human Parainfluenza Viruses Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Parainfluenza Viruses Diagnostics market, Segment by Type:
HPV Testing
Follow-up HPV Testing
Co-testing
Global Human Parainfluenza Viruses Diagnostics market, by Application
Diagnostic Centers
Hospitals
Clinic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Human Parainfluenza Viruses Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
The global Human Parainfluenza Viruses Diagnostics market size is expected to reach US$ 935.8 million by 2029, growing at a CAGR of 8.3% from 2023 to 2029. The market is mainly driven by the significant applications of Human Parainfluenza Viruses Diagnostics in various end use industries. The expanding demands from the Diagnostic Centers, Hospitals and Clinic,, are propelling Human Parainfluenza Viruses Diagnostics market. HPV Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Follow-up HPV Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Parainfluenza Viruses Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Parainfluenza Viruses Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Parainfluenza Viruses Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Parainfluenza Viruses Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Parainfluenza Viruses Diagnostics covered in this report include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD and Seegene, etc.
The global Human Parainfluenza Viruses Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene
Global Human Parainfluenza Viruses Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Parainfluenza Viruses Diagnostics market, Segment by Type:
HPV Testing
Follow-up HPV Testing
Co-testing
Global Human Parainfluenza Viruses Diagnostics market, by Application
Diagnostic Centers
Hospitals
Clinic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Human Parainfluenza Viruses Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Human Parainfluenza Viruses Diagnostics
1.1 Human Parainfluenza Viruses Diagnostics Market Overview
1.1.1 Human Parainfluenza Viruses Diagnostics Product Scope
1.1.2 Human Parainfluenza Viruses Diagnostics Market Status and Outlook
1.2 Global Human Parainfluenza Viruses Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Human Parainfluenza Viruses Diagnostics Market Size by Region (2018-2029)
1.4 Global Human Parainfluenza Viruses Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Human Parainfluenza Viruses Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Human Parainfluenza Viruses Diagnostics Market Size (2018-2029)
1.6.1 North America Human Parainfluenza Viruses Diagnostics Market Size (2018-2029)
1.6.2 Europe Human Parainfluenza Viruses Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size (2018-2029)
1.6.4 Latin America Human Parainfluenza Viruses Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size (2018-2029)
2 Human Parainfluenza Viruses Diagnostics Market by Type
2.1 Introduction
2.1.1 HPV Testing
2.1.2 Follow-up HPV Testing
2.1.3 Co-testing
2.2 Global Human Parainfluenza Viruses Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Human Parainfluenza Viruses Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Human Parainfluenza Viruses Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Human Parainfluenza Viruses Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Human Parainfluenza Viruses Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Human Parainfluenza Viruses Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Human Parainfluenza Viruses Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Human Parainfluenza Viruses Diagnostics Revenue Breakdown by Type (2018-2029)
3 Human Parainfluenza Viruses Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic Centers
3.1.2 Hospitals
3.1.3 Clinic
3.2 Global Human Parainfluenza Viruses Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Human Parainfluenza Viruses Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Human Parainfluenza Viruses Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Human Parainfluenza Viruses Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Human Parainfluenza Viruses Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Human Parainfluenza Viruses Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Human Parainfluenza Viruses Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Human Parainfluenza Viruses Diagnostics Revenue Breakdown by Application (2018-2029)
4 Human Parainfluenza Viruses Diagnostics Competition Analysis by Players
4.1 Global Human Parainfluenza Viruses Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Parainfluenza Viruses Diagnostics as of 2022)
4.3 Date of Key Players Enter into Human Parainfluenza Viruses Diagnostics Market
4.4 Global Top Players Human Parainfluenza Viruses Diagnostics Headquarters and Area Served
4.5 Key Players Human Parainfluenza Viruses Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Human Parainfluenza Viruses Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Qiagen
5.1.1 Qiagen Profile
5.1.2 Qiagen Main Business
5.1.3 Qiagen Human Parainfluenza Viruses Diagnostics Products, Services and Solutions
5.1.4 Qiagen Human Parainfluenza Viruses Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Qiagen Recent Developments
5.2 Roche Diagnostics
5.2.1 Roche Diagnostics Profile
5.2.2 Roche Diagnostics Main Business
5.2.3 Roche Diagnostics Human Parainfluenza Viruses Diagnostics Products, Services and Solutions
5.2.4 Roche Diagnostics Human Parainfluenza Viruses Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Diagnostics Recent Developments
5.3 Hologic
5.3.1 Hologic Profile
5.3.2 Hologic Main Business
5.3.3 Hologic Human Parainfluenza Viruses Diagnostics Products, Services and Solutions
5.3.4 Hologic Human Parainfluenza Viruses Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Laboratories Recent Developments
5.4 Abbott Laboratories
5.4.1 Abbott Laboratories Profile
5.4.2 Abbott Laboratories Main Business
5.4.3 Abbott Laboratories Human Parainfluenza Viruses Diagnostics Products, Services and Solutions
5.4.4 Abbott Laboratories Human Parainfluenza Viruses Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Laboratories Recent Developments
5.5 BD
5.5.1 BD Profile
5.5.2 BD Main Business
5.5.3 BD Human Parainfluenza Viruses Diagnostics Products, Services and Solutions
5.5.4 BD Human Parainfluenza Viruses Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 BD Recent Developments
5.6 Seegene
5.6.1 Seegene Profile
5.6.2 Seegene Main Business
5.6.3 Seegene Human Parainfluenza Viruses Diagnostics Products, Services and Solutions
5.6.4 Seegene Human Parainfluenza Viruses Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Seegene Recent Developments
6 North America
6.1 North America Human Parainfluenza Viruses Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Human Parainfluenza Viruses Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Human Parainfluenza Viruses Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Human Parainfluenza Viruses Diagnostics Market Dynamics
11.1 Human Parainfluenza Viruses Diagnostics Industry Trends
11.2 Human Parainfluenza Viruses Diagnostics Market Drivers
11.3 Human Parainfluenza Viruses Diagnostics Market Challenges
11.4 Human Parainfluenza Viruses Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
